NCT02242331View on ClinicalTrials.gov

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

CompletedOBSERVATIONAL
Enrollment

19,805

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

May 31, 2002

Conditions
Hypertension
Interventions
DRUG

Micardis®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242331 - Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure | Biotech Hunter | Biotech Hunter